“Remember why you’re doing the work that you do…” -Mona Fouad, M.D., MPH

UAB, September 12, 2024

Subramaniam Appointed as Division Director for UAB Maternal-Fetal Medicine

July 26, 2024, Hadley Turner, UAB Heersink School of Medicine

Akila Subramaniam, M.D.

The UAB Department of Obstetrics and Gynecology announces Akila Subramaniam, M.D. as the Division Director for the Maternal-Fetal Medicine (MFM) effective August 1, 2024. This transition marks an exciting new chapter for this division, and we are thrilled to see Dr. Subramaniam take on this pivotal leadership role.

Subramaniam has already made significant contributions within the department, particularly during her time serving as Interim Division Director following the departure of Brian Casey, M.D. to West Virginia University. Her leadership during this period has been instrumental in guiding the division through this transition.

Dr. Subramaniam’s academic and professional background is nothing short of remarkable. A native of Metairie, Louisiana, she earned her Bachelor of Science from the Massachusetts Institute of Technology in 2004 and pursued post-graduate work in Social Policy at the London School of Economics and Political Science in 2003. Her pursuit of excellence continued with her Doctor of Medicine and Master of Public Health degrees from Louisiana State University Health Sciences Center in New Orleans in 2008. She completed her residency in Obstetrics and Gynecology at UAB in 2012, followed by a combined fellowship in Maternal Fetal Medicine and Medical Genetics at UAB in 2016. She is presently an Associate Professor with Tenure and holds the Bruce Harris, Jr., MD, Endowed Professorship in Obstetrics/Gynecology.

UAB Center for Women’s Reproductive Health (CWRH) Seminar – Jul 26, 2024

Jul 26, 2024

CWRH Seminar: TODAY at 12:30pm (CST) . Dr. Bill Andrews will present: “From Meager Beginnings to a Powerhouse: The Expansion of Women’s Health at UAB.” Dr. Rachel Sinkey will present “Spotlight on Maternal and Infant Health Equity”. Register here: https://uab.zoom.us/meeting/register/tZEuc-GupzovGd3c62X3_UahVVpXAqt1yuFo#/registration

.

Celebrating #WomensHealthWeek with a look back to the early 2000s, when Dr. Mona Fouad & Edward E. Partridge began work to fight breast and cervical cancer disparities.

May 16, 2024

Tita, Carlo, and Team Win Distinguished Clinical Research Achievement Award

UAB CCTS, Apr 15, 2024

A-PLUS co-leads Alan Tita, M.D., Ph.D. and Waldemar A. Carlo, M.D. Photography: Andrea Mabry
Alan Tita, M.D., Ph.D. and Waldemar A. Carlo, M.D.

The Clinical Research (CR) Forum, a non-profit membership association of top clinical research experts and thought leaders from the nation’s leading academic health centers, presented the Distinguished Clinical Research Achievement Award to two outstanding studies at the Top Ten Clinical Research Achievement Awards on April 2nd at the Paris Hotel Las Vegas, and for the second year in a row, CCTS investigators were recognized for their achievements.

This year, the CRF awarded the study entitled “Azithromycin to Prevent Sepsis or Death in Women Planning a Vaginal Birth (A-PLUS),” led by Dr. Waldemar Carlo, Professor of Pediatrics, co-Division Director of Neonatology and Edwin M. Dixon Endowed Chair, and Dr. Alan Tita, Professor and Senior Vice Chair for research and innovation in UAB’s Obstetrics and Gynecology Department. The A-PLUS trial represents a landmark study with global reach enrolling more than 29,000 women in seven low- and middle-income countries with significant health disparities. Published in the New England Journal of Medicine in 2023, the project created an evidence base for a low-cost intervention that can be used to reduce maternal sepsis and deaths in underserved regions on a global scale.

The CR Forum presents its annual Top Ten Clinical Research Achievement Awards to highlight outstanding research advances that involve both innovation and impact on human diseases. A complete list of the 2024 Top Ten Award Winners can be found at www.clinicalresearchforum.org.

“This year’s award winners demonstrate the immense value of our nation’s investment in clinical research, and the direct impact of that work on the health of millions of people in the United States,” said Harry P. Selker, MD, MSPH, CR Forum Board Chair and Dean of the Clinical and Translational Science Institute at Tufts University. “For many, these innovative studies and related clinical trials may represent the only hope for surviving a life-threatening disease. They also pave the way to advance new therapies and treatments that improve public health.”

The Distinguished Clinical Research Achievement Award is presented to the top two studies that show creativity, innovation, or a novel approach that demonstrates an immediate impact on the health and well-being of patients. The study, “Azithromycin to Prevent Sepsis or Death in Women Planning a Vaginal Birth,” is one of this year’s honorees.

Contribution of Health Care Practitioner and Maternity Services Factors to Racial Disparities in Alabama

Oct 9, 2023

A Qualitative Study

Toluhi, Angelina A. MD, MPH; Richardson, Molly R. MPH, PhD; Julian, Zoe I. MD, MPH; Sinkey, Rachel G. MD; Knight, Candace C. PhD; Budhwani, Henna MPH, PhD; Szychowski, Jeff M. PhD; Wingate, Martha S. DrPH, MPH; Tita, Alan T. MD, PhD; Baskin, Monica L. MS, PhD; Turan, Janet M. MPH, PhD

Obstetrics & Gynecology 142(4):p 873-885, October 2023. | DOI: 10.1097/AOG.0000000000005326

The authors attempt to uncover the factors related to practitioners and health care services that lead to inequities in maternal health in Alabama.

Congratulations to our MHIGH director Alan Tita, MD, PhD for his induction today into the National Academy of Medicine!

UAB Mary Heersink Institute for Global Health, Oct 7, 2023

Congratulations to our MHIGH director @atitapatterns for his induction today into the National Academy of Medicine!

Fouad elected to exclusive NIH advisory committee

Heersink School Medicine News, Mary Ashley Canevaro, September 26, 2023

Mona Fouad, M.D., MPH

Mona Fouad, M.D., MPH, senior associate dean for Diversity and Inclusion in the Heersink School of Medicine and director of the Minority Health and Health Equity Research Center, has been elected to the National Institutes of Health’s Advisory Committee to the Director (ACD) Working Group on Diversity.

The ACD Working Group on Diversity seeks to develop effective diversity-related strategies for the National Institutes of Health (NIH) on research. Some of their priorities include enhancing access and opportunities for the biomedical research workforce to nurture a diverse community, identifying strategies to address underfunding of minority health and health disparities research, and advancing programs that enhance recruitment and retention of individuals from wide-ranging backgrounds. The group also advises on policy and procedural changes relating to addressing disparities in research, training, and professional development.

Fouad sits among a small, selected group of experts from nationally renowned institutions, including Yale University, Hopkins Medicine, University of Michigan, and New York University, among others.